EDIT earnings: a positive outcome, +13.4%

On August 3, 2022, Editas Medicine, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.4% in the window around the event. It had already run +26.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.